Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
City View Green HoldingsCVGRF 3-Year EBITDA Growth Rate is 18.80% as of Mar. 2026, which is 47% below its 10-year median of 35.20. The stock has 2 warning signs investors should review. Among 810 Drug Manufacturers companies, City View Green Holdings ranks better than 66.17% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 18.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 41.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 24.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of City View Green Holdings was 78.00% per year. The lowest was -136.40% per year. And the median was 35.20% per year.
City View Green Holdings (OTCPK:CVGRF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
City View Green Holdings 3-Year EBITDA Growth Rate Related Terms
CVGRF vs ZTS: 3-Year EBITDA Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, City View Green Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
City View Green Holdings 3-Year EBITDA Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, City View Green Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where City View Green Holdings's 3-Year EBITDA Growth Rate falls into.
City View Green Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 18.80% mean?
City View Green Holdings (CVGRF) has a 3-Year EBITDA Growth Rate of 18.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for City View Green Holdings and its competitors. This is 47% below median its historical median of 35.20. According to the industry distribution chart, City View Green Holdings ranks #274 out of 810 companies in the Drug Manufacturers industry, placing it in the top 33.8%.
Is City View Green Holdings' 3-Year EBITDA Growth Rate too high?
City View Green Holdings' current 3-Year EBITDA Growth Rate of 18.80% is 47% below median its 10-year median of 35.20. The Drug Manufacturers industry median 3-Year EBITDA Growth Rate is 8.90. City View Green Holdings' value of 18.80% is 111.2% above this industry median. Based on the distribution chart, City View Green Holdings ranks #274 out of 810 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does City View Green Holdings' 3-Year EBITDA Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, City View Green Holdings ranks #274 out of 810 companies for 3-Year EBITDA Growth Rate. This puts City View Green Holdings in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.90. City View Green Holdings' value of 18.80% is 111.2% above this benchmark. While the company's 10-year median is 35.20 vs. the industry median of 8.90, City View Green Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Drug Manufacturers company?
The median 3-Year EBITDA Growth Rate among Drug Manufacturers companies is 8.90, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. City View Green Holdings's current 3-Year EBITDA Growth Rate of 18.80% is 111.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for City View Green Holdings and its competitors. For the Drug Manufacturers industry, the median 3-Year EBITDA Growth Rate is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. City View Green Holdings's current 3-Year EBITDA Growth Rate is 18.80%, which is 47% below median its own 10-year median of 35.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is City View Green Holdings stock overvalued right now?
City View Green Holdings (CVGRF) has a current 3-Year EBITDA Growth Rate of 18.80%. The current 3-Year EBITDA Growth Rate is 18.80%, which is 47% below median its 10-year median of 35.20 and 111.2% above the Drug Manufacturers industry median of 8.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For City View Green Holdings (CVGRF), the current 3-Year EBITDA Growth Rate is 18.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
City View Green Holdings Inc is a cannabis company focused on the cultivation, extraction, and production of cannabis products for the medicinal and adult-use markets in Canada. The company operates a facility in Brantford, Ontario, with cultivation and extraction capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVGRF has been successfully added to your 
